PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

The 10-point guide to the integral management of menopausal health

2015-03-16
(Press-News.org) Amsterdam, March 16, 2015 - Elsevier journal Maturitas, today announced the publication of a position statement by the European Menopause and Andropause Society (EMAS) covering the ten- point guide to the integral management of menopausal health. This has been written to mark the 10th EMAS Congress in Madrid May 20-22, 2015.

With increased longevity and more women becoming centenarians, management of the menopause and post-reproductive health is of growing importance as it has the potential to help promote health over several decades. Women have individual needs and the approach needs to be personalized. The position statement provides a short integral guide for all those involved in menopausal health.

For most women the menopause is a natural and inevitable process due to ovarian ageing which usually occurs in women in their late 40s or early 50s. However, it can be induced earlier by medical intervention such as bilateral oophorectomy or iatrogenic ablation of ovarian function by chemotherapy, radiotherapy or treatment with gonadotrophin-releasing hormone analogues. Discussions with patients about the menopause are becoming more complex because of the wide range of therapeutic options, the controversies regarding menopausal hormone therapy and the increasing use of alternative and complementary therapies.

EMAS is therefore producing a simple ten point guide to help physicians and allied health professionals from all specialties deal with menopausal and post-reproductive health. It covers diagnosis, screening for diseases in later life, treatment and follow up.

It must be remembered that women have individual needs and the approach needs to be personalized.

These and other recommendations presented in EMAS' position statement are published in the article: "EMAS Position statement: the ten point guide to the integral management of menopausal health" (doi:10.1016/j.maturitas.2015.02.003) in Maturitas published by Elsevier.

INFORMATION:

Notes for editors Copies of this paper are available to credentialed journalists upon request; please contact Elsevier's Newsroom at newsroom@elsevier.com or +31 20 4853564

About European Menopause and Andropause Society (EMAS) EMAS promotes the study of midlife health through its journal, congresses, schools and website and encourages the exchange of research and professional experience between members. Using a range of activities and through its affiliates, EMAS aims to guarantee and provide the same standard of education and information throughout Europe on midlife health in both genders. Recognizing the issues arising from increased longevity the society also provides articles, patient information, web resources, and referrals for healthcare providers in the field and keeps its members up-to-date. For more information go to: http://www.emas-online.org

About Maturitas Maturitas is an international multidisciplinary peer reviewed scientific journal of midlife health and beyond, publishing original research, reviews, consensus statements and guidelines. The scope encompasses all aspects of postreproductive health in both genders ranging from basic science to health and social care. http://www.maturitas.org/

About Elsevier Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes over 2,500 journals, including The Lancet and Cell, and more than 33,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group plc, a world-leading provider of information solutions for professional customers across industries.



ELSE PRESS RELEASES FROM THIS DATE:

American College of Cardiology's 64th Annual Scientific Session AM tip sheet

2015-03-16
The studies below will be presented at the American College of Cardiology's 64th Annual Scientific Session the morning of Saturday, March 14. 1. Depression May Influence Cardiovascular Outcomes A new study adds to the evidence that depression may influence cardiovascular outcomes, prompting authors to call on cardiologists to pay closer attention to depression when managing patients with heart disease. Researchers at Care Institute of Medical Sciences in India found depression to be independently associated with a greater chance of cardiovascular death and lower quality ...

Heart CT scans show slight benefits over functional tests for heart disease

2015-03-16
Patients with symptoms of heart disease have similar outcomes in terms of death and major cardiac conditions regardless of whether they undergo a functional stress test or a computed tomographic scan, but the scan may be better at ruling out the need for subsequent tests and procedures in patients who are free of heart disease, according to research presented at the American College of Cardiology's 64th Annual Scientific Session in San Diego. The PROMISE trial is the first-ever randomized controlled trial to compare clinical outcomes in patients receiving functional stress ...

Long-term ticagrelor cuts risk of future events after heart attack

2015-03-16
SAN DIEGO (March 14, 2015) -- Adding the antiplatelet drug ticagrelor to aspirin as long-term therapy after a heart attack significantly reduced the rate of subsequent death from cardiovascular causes, heart attack or stroke, with the benefit appearing to accrue for nearly three years, according to a study presented at the American College of Cardiology's 64th Annual Scientific Session. The double-blind PEGASUS-TIMI 54 trial recruited 21,162 patients who had experienced a heart attack in the previous one to three years. Each had another factor, such as age or diabetes, ...

No real cost difference between types of tests that look for heart disease

2015-03-16
SAN DIEGO (March 14, 2015) -- A study comparing the overall economics of computed tomographic angiography with functional stress tests for evaluating patients with symptoms suggestive of possible blocked coronary arteries found no significant differences in costs over three years. The study was presented at the American College of Cardiology's 64th Annual Scientific Session. Although the angiography, scans of the heart referred to as CT angiography, initially appeared to provide some cost savings, this didn't hold up once the costs of subsequent testing and procedures ...

American College of Cardiology's 64th Annual Scientific Session PM tip sheet for March 14, 2015

2015-03-16
The studies below will be presented at the American College of Cardiology's 64th Annual Scientific Session the afternoon of Saturday, March 14. 1. Energy Drink Shown to Raise Resting Blood Pressure Medical reports have linked energy drink consumption to adverse cardiac events such as changes in heart rhythm, heart attacks and even deaths in otherwise healthy people. To investigate how energy drinks affect the heart, researchers alternately gave a can of commercially available energy drink or a placebo drink to 25 healthy young adults (age 19-40 years) and assessed changes ...

Scientists fly kites on Earth to study Mars

Scientists fly kites on Earth to study Mars
2015-03-16
Scientists of the University of Arizona's Lunar and Planetary Laboratory have taken to kites that they fly above lava flows blanketing the Hawaiian landscape to unravel the past mysteries that shaped Mars. A kite, equipped with off-the-shelf instruments such as a camera, a GPS, and orientation sensors, scans the terrain from high above. The team then employs parallel computing and powerful software algorithms to assemble tens of thousands of images into extremely detailed and accurate 3D digital terrain models. In terms of studying volcanic landscapes, the project is ...

A more tolerant America?

2015-03-16
SAN DIEGO, Calif. (March 16, 2015)-- As the nation's headlines turn more and more to issues of tolerance -- race, religion, free speech, same sex marriage -- research by San Diego State University Psychology Professor Jean M. Twenge shows that Americans are actually more tolerant than ever before. In a paper released this month by the journal Social Forces, Twenge, along with Nathan T. Carter and Keith Campbell from the University of Georgia, found that Americans are now more likely to believe that people with different views and lifestyles can and should have the same ...

'Sharenting' trends: Do parents share too much about kids on social media?

Sharenting trends: Do parents share too much about kids on social media?
2015-03-16
ANN ARBOR, Mich. -- Some of social media's greatest stars aren't even old enough to tweet: Pictures of kids playing dress up, having meltdowns and even in the bathtub adorn Facebook walls. Diaper-donning toddlers dancing to the likes of Beyonce and Taylor Swift rack up YouTube views. Countless blogs share stories about everything from potty training to preschool struggles. Today's University of Michigan C.S. Mott Children's Hospital National Poll on Children's Health finds that this so-called "sharenting" isn't going anywhere anytime soon, with more than half of mothers ...

Hydrazine is not a prevalent contaminant in smokeless tobacco products

2015-03-16
After many years of speculation, it has finally been established that hydrazine is not a prevalent contaminant in contemporary smokeless tobacco products (STPs). The presence of hydrazine has only been reported once in a limited sample of cigarette tobacco and tobacco smoke some 40 years ago1. But this study has been cited many times as evidence that hydrazine is present in smokeless tobacco products. To date, no one has examined STPs for its presence. Hydrazine is found in maleic hydrazine, which is used as a sucker growth inhibitor on tobacco crops - suckers are ...

Oncologists reveal reasons for high cost of cancer drugs in the US, recommend solutions

2015-03-16
ROCHESTER, Minn. - Increasingly high prices for cancer drugs are affecting patient care in the U.S. and the American health care system overall, say the authors of a special article published online in the journal Mayo Clinic Proceedings. "Americans with cancer pay 50 percent to 100 percent more for the same patented drug than patients in other countries," says S. Vincent Rajkumar, M.D., of Mayo Clinic Cancer Center, who is one of the authors. "As oncologists we have a moral obligation to advocate for affordable cancer drugs for our patients." Dr. Rajkumar and his colleague, ...

LAST 30 PRESS RELEASES:

Making lighter work of calculating fluid and heat flow

Normalizing blood sugar can halve heart attack risk

Lowering blood sugar cuts heart attack risk in people with prediabetes

Study links genetic variants to risk of blinding eye disease in premature infants

Non-opioid ‘pain sponge’ therapy halts cartilage degeneration and relieves chronic pain

AI can pick up cultural values by mimicking how kids learn

China’s ecological redlines offer fast track to 30 x 30 global conservation goal

Invisible indoor threats: emerging household contaminants and their growing risks to human health

Adding antibody treatment to chemo boosts outcomes for children with rare cancer

Germline pathogenic variants among women without a history of breast cancer

Tanning beds triple melanoma risk, potentially causing broad DNA damage

Unique bond identified as key to viral infection speed

Indoor tanning makes youthful skin much older on a genetic level

Mouse model sheds new light on the causes and potential solutions to human GI problems linked to muscular dystrophy

The Journal of Nuclear Medicine ahead-of-print tip sheet: December 12, 2025

Smarter tools for peering into the microscopic world

Applications open for funding to conduct research in the Kinsey Institute archives

Global measure underestimates the severity of food insecurity

Child survivors of critical illness are missing out on timely follow up care

Risk-based vs annual breast cancer screening / the WISDOM randomized clinical trial

University of Toronto launches Electric Vehicle Innovation Ontario to accelerate advanced EV technologies and build Canada’s innovation advantage

Early relapse predicts poor outcomes in aggressive blood cancer

American College of Lifestyle Medicine applauds two CMS models aligned with lifestyle medicine practice and reimbursement

Clinical trial finds cannabis use not a barrier to quitting nicotine vaping

Supplemental nutrition assistance program policies and food insecurity

Switching immune cells to “night mode” could limit damage after a heart attack, study suggests

URI-based Global RIghts Project report spotlights continued troubling trends in worldwide inhumane treatment

Neutrophils are less aggressive at night, explaining why nighttime heart attacks cause less damage than daytime events

Menopausal hormone therapy may not pose breast cancer risk for women with BRCA mutations

Mobile health tool may improve quality of life for adolescent and young adult breast cancer survivors

[Press-News.org] The 10-point guide to the integral management of menopausal health